Breaking News Instant updates and real-time market news.

FB

Facebook

$143.80

1.53 (1.08%)

09:02
04/21/17
04/21
09:02
04/21/17
09:02

Facebook Q1 results likely to beat expectations, says MKM Partners

MKM Partners analyst Rob Sanderson expects Facebook's Q1 results to beat expectations, and he believes that the company's "tone" on the the likely deceleration of ad load growth in 2H17 has "softened." He adds that user growth and engagement will continue to be an area of focus, given "greater focus" on competition from Snapchat (SNAP). However, he continues to believe that Facebook is "a core holding for growth investors" and keeps a Buy rating.

  • 03

    May

FB Facebook
$143.80

1.53 (1.08%)

04/17/17
JEFF
04/17/17
NO CHANGE
Target $30
JEFF
Buy
Jefferies sees potential upside to Snap's Q1 results after survey
After surveying 1,000 internet users in the U.S. aged 18-45 who use both Facebook (FB) and Snap's (SNAP) Snapchat, Jefferies analyst Brian Fitzgerald believes there could be upside to Snap's Q1 results. The survey found that both Instagram and Snapchat are seeing continued user growth, with Snapchat usage growing fastest among the older demographic, Fitzgerald tells investors in a research note. The analyst also believes Snap's recent improvements to targeting and the increase gamified ad formats will help drive average revenue per user growth over time. Fitzgerald keeps a Buy rating on Snap with a $30 price target. The stock closed Thursday down 1c to $20.19.
04/17/17
FBCO
04/17/17
NO CHANGE
Target $175
FBCO
Outperform
Facebook price target raised to $175 from $170 at Credit Suisse
Credit Suisse analyst Stephen Ju raised his price target for Facebook to $175 from $170 ahead of Q1 results, and as he increases his ad volume growth estimates for 2H17 from what he felt was "an excessively conservative" level, offset by higher anticipated content spend. The analyst reiterates an Outperform rating on the shares.
04/17/17
AGIS
04/17/17
NO CHANGE
Target $160
AGIS
Buy
Facebook price target raised to $160 ahead of F8, earnings at Aegis
Aegis analyst Victor Anthony said he expects Facebook's annual "F8" developer conference this week and the company's Q1 earnings report on May 3 to both be catalysts for the stock and raised his price target on the shares to $160 from $155 ahead of the events. He expects F8 to focus on innovations with the camera and video and he predicts the company will report solid quarterly results given strong advertiser checks. Anthony keeps a Buy rating on Facebook shares.
04/19/17
MSCN
04/19/17
NO CHANGE
MSCN
Facebook overall trends remain 'very strong,' says MScience
MScience analyst Steven Weinstein is forecasting Facebook's North American revenues of 4.07B, down slightly from $4.08B, above consensus of $4.005B. The analyst said slowing increases in US spending per advertiser led to a modest deceleration in revenue growth, but these trends are reflected in management's comments regarding ad load leveling off. Weinstein views overall trends as "very strong."

TODAY'S FREE FLY STORIES

SAGE

SAGE Therapeutics

$72.82

1.19 (1.66%)

07:29
04/24/17
04/24
07:29
04/24/17
07:29
Hot Stocks
Feuerstein says 'stand down' on SAGE takeout after Cloonan hire »

Adam Feuerstein tweeted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$81.89

-0.05 (-0.06%)

07:29
04/24/17
04/24
07:29
04/24/17
07:29
Recommendations
Eli Lilly analyst commentary  »

Eli Lilly Q1 results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

  • 07

    May

SCYX

SCYNEXIS

$2.57

0.03 (1.18%)

07:28
04/24/17
04/24
07:28
04/24/17
07:28
Technical Analysis
SCYNEXIS trades sharply higher on light pre-market volume »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

TRUE

TrueCar

$15.26

-0.06 (-0.39%)

07:27
04/24/17
04/24
07:27
04/24/17
07:27
Syndicate
TrueCar files to sell 8.5M shares of common stock »

TrueCar expects to offer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

GE

General Electric

$29.55

-0.72 (-2.38%)

07:26
04/24/17
04/24
07:26
04/24/17
07:26
Periodicals
GE CFO Bornstein concerned over U.S. business confidence, FT reports »

General Electric CFO Jeff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 09

    May

  • 22

    Jun

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

, BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

07:25
04/24/17
04/24
07:25
04/24/17
07:25
Recommendations
C.R. Bard, Becton Dickinson analyst commentary  »

C.R. Bard price target…

BCR

C.R. Bard

$253.07

-1.7 (-0.67%)

BDX

Becton Dickinson

$185.29

-0.76 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

07:25
04/24/17
04/24
07:25
04/24/17
07:25
General news
FX Update: The euro surged »

FX Update: The euro…

MTSI

MACOM

$51.74

-0.07 (-0.14%)

, SBGI

Sinclair Broadcast

$39.90

-0.45 (-1.12%)

07:24
04/24/17
04/24
07:24
04/24/17
07:24
Conference/Events
National Association of Broadcasters to hold a conference »

NAB Show 2017 is being…

MTSI

MACOM

$51.74

-0.07 (-0.14%)

SBGI

Sinclair Broadcast

$39.90

-0.45 (-1.12%)

NXST

Nexstar

$69.10

0.3 (0.44%)

TRCO

Tribune Media

$37.35

-0.77 (-2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    May

  • 09

    May

  • 22

    May

  • 23

    May

BUD

AB InBev

$108.28

-0.81 (-0.74%)

07:24
04/24/17
04/24
07:24
04/24/17
07:24
Technical Analysis
AB InBev rallies in early pre-market trading »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMS

Adamas Pharmaceuticals

$15.57

-0.05 (-0.32%)

, AVXS

AveXis

$76.76

-0.24 (-0.31%)

07:23
04/24/17
04/24
07:23
04/24/17
07:23
Conference/Events
American Academy of Neurology »

69th Annual Meeting of…

ADMS

Adamas Pharmaceuticals

$15.57

-0.05 (-0.32%)

AVXS

AveXis

$76.76

-0.24 (-0.31%)

CATB

Catabasis Pharmaceuticals

$1.45

-0.07 (-4.61%)

MNOV

MediciNova

$5.83

0.08 (1.39%)

IONS

Ionis Pharmaceuticals

$44.26

1.35 (3.15%)

FLKS

Flex Pharma

$3.08

-0.5 (-13.97%)

TGTX

TG Therapeutics

$10.30

-0.15 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 24

    May

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 24

    Aug

VAC

Marriott Vacations

$104.42

1.54 (1.50%)

, WYN

Wyndham

$89.72

-0.03 (-0.03%)

07:22
04/24/17
04/24
07:22
04/24/17
07:22
Recommendations
Marriott Vacations, Wyndham, Extended Stay America analyst commentary  »

A few hotel chanins…

VAC

Marriott Vacations

$104.42

1.54 (1.50%)

WYN

Wyndham

$89.72

-0.03 (-0.03%)

STAY

Extended Stay America

$17.24

-0.07 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 04

    May

CGIX

Cancer Genetics

$4.05

0.1 (2.53%)

07:21
04/24/17
04/24
07:21
04/24/17
07:21
Hot Stocks
Cancer Genetics launches Complete::IO panel »

Cancer Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRV

Travelers

$119.10

0.22 (0.19%)

07:21
04/24/17
04/24
07:21
04/24/17
07:21
Upgrade
Travelers rating change  »

Travelers upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLT

FleetCor

$147.66

-2.07 (-1.38%)

07:21
04/24/17
04/24
07:21
04/24/17
07:21
Recommendations
FleetCor analyst commentary  »

FleetCor should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

DB

Deutsche Bank

$16.50

-0.05 (-0.30%)

07:21
04/24/17
04/24
07:21
04/24/17
07:21
Technical Analysis
Deutsche Bank rallies sharply in pre-market »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLJ

RLJ Lodging Trust

$23.60

-0.2 (-0.84%)

, FCH

Felcor Lodging

$7.32

-0.05 (-0.68%)

07:20
04/24/17
04/24
07:20
04/24/17
07:20
Conference/Events
RLJ Lodging Trust and Felcor Lodging to host joint conference call »

Joint Conference call to…

RLJ

RLJ Lodging Trust

$23.60

-0.2 (-0.84%)

FCH

Felcor Lodging

$7.32

-0.05 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 28

    Apr

AKTX

Akari Therapeutics

$20.50

4.13 (25.23%)

07:16
04/24/17
04/24
07:16
04/24/17
07:16
Hot Stocks
Akari: Interim Phase 2 PNH data demonstrate 'positive' response with Coversin »

Akari Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

WGO

Winnebago

$26.25

0.15 (0.57%)

07:15
04/24/17
04/24
07:15
04/24/17
07:15
Initiation
Winnebago initiated  »

Winnebago initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$104.89

0.01 (0.01%)

07:14
04/24/17
04/24
07:14
04/24/17
07:14
Periodicals
Chevron to sell Bangladesh gas fields to Himalaya Energy, Reuters says »

Chevron has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 31

    May

QTS

QTS Realty Trust

$52.90

-0.14 (-0.26%)

07:12
04/24/17
04/24
07:12
04/24/17
07:12
Recommendations
QTS Realty Trust analyst commentary  »

QTS Realty Trust named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

CARA

Cara Therapeutics

$16.53

-0.56 (-3.28%)

07:12
04/24/17
04/24
07:12
04/24/17
07:12
Hot Stocks
Cara Therapeutics announces 'positive' data from Phase 1 trial of CR845 »

Cara Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

STLD

Steel Dynamics

$35.37

0.46 (1.32%)

07:10
04/24/17
04/24
07:10
04/24/17
07:10
Upgrade
Steel Dynamics rating change  »

Steel Dynamics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

$6.72

-0.1 (-1.47%)

07:10
04/24/17
04/24
07:10
04/24/17
07:10
Upgrade
AK Steel rating change  »

AK Steel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    May

NUE

Nucor

$60.00

-0.35 (-0.58%)

07:10
04/24/17
04/24
07:10
04/24/17
07:10
Upgrade
Nucor rating change  »

Nucor upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

X

U.S. Steel

$30.42

-0.09 (-0.29%)

07:10
04/24/17
04/24
07:10
04/24/17
07:10
Upgrade
U.S. Steel rating change  »

U.S. Steel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.